Stada Grabs GSK Brands In Key EU Markets
Stada says it has become a "major consumer healthcare player" after signing a deal to acquire from GSK 15 brands, which generate annual sales in excess of €100m.
You may also be interested in...
Stada hires Accord's Romaniszyn to lead its business in Poland; Bayer extends the contract of chairman Werner Baumann; and France's Anses appoints a new chair of the board.
EU Business Round-Up: Stada Enters Germany Top-5, Dr Wolff Takes Vagisan To Poland, Fidia And Sanova Strike Nasal Spray Deals
Acquiring six brands from GSK has propelled Stada into Germany's OTC top-5; Dr. Wolff has secured distribution for its Vagisan women's health brand in Poland; and Sanova and Fidia have added innovative nasal sprays to their respective portfolios.
Exclusive: HBW Insight talks to Stada executive vice-president Roger Scarlett-Smith on the progress of the company's ambitious growth strategy, the impact of the coronavirus and its new innovation centre in Yorkshire, England.